ICYMI: Bioprinted placenta organoids

Bioprinted placenta organoids

ICYMI: Bioengineering a live biotherapeutic product from bench to business

Genetically targeted chemical assembly uses cell-specific genetic information to guide the assembly of functional materials in situ. This article discusses how this concept can be applied for fundamental research and the treatment of diseases:

Bioengineering a live biotherapeutic product from bench to business

ICYMI: Low-dimensional materials for bioelectronic devices

ICYMI: Magnetobacterial microrobots

Magnetobacterial microrobots

Low-dimensional materials for bioelectronic devices

Infections associated with medical device use can have serious consequences for patients, which might be addressed using medical devices with antimicrobial effects. This article discusses preclinical performance testing of medical devices with antimicrobial effects:

ICYMI: Bio-inspired navigation systems for robots

ICYMI: Engaging students with soft robotics

Bio-inspired navigation systems for robots

Engaging students with soft robotics

Tumour heterogeneity comes at different length scales.This article classifies regulators of cancer into tumour-cell-intrinsic, tissue-microenvironment and organism-level sources, describing engineering strategies to measure and analyse these factors:

ICYMI: Soft robotics for personalized and sustainable wearables

ICYMI: Non-model bacteria as platforms for endogenous gene expression in synthetic biology

ICYMI: Energy-saving movement strategies in animals and plants for robot design

Ischaemic stroke remains a leading cause of disability. This article discusses the design of biomaterials that can engage and modulate pro-repair mechanisms in the brain to improve repair after ischaemic stroke:

Energy-saving movement strategies in animals and plants for robot design

Non-model bacteria as platforms for endogenous gene expression in synthetic biology

Soft robotics for personalized and sustainable wearables

Kidney transplantation is the only definitive treatment for end-stage kidney disease. This article explores challenges in renal replacement and highlights the clinical potential of bioengineering approaches to restore kidney function:

The clinical application of CAR T cell therapy remains limited owing to off-target toxicity. This article discusses the remote and spatiotemporal control of CAR T cells by combining stimuli-responsive nanotechnologies with immunoengineering:

In this @natrevbioeng.nature.com paper, Core Faculty member @geochurch.bsky.social, Postdoc Li Li, and their colleagues offer an actionable, practical roadmap for integrating AI tools into protein design, including step-by-step guidance and case studies that demonstrate this roadmap in action.

ICYMI: Targeting metastasis with nanomedicine

ICYMI: The untapped potential of mRNA–lipid nanoparticles

Targeting metastasis with nanomedicine

The untapped potential of mRNA–lipid nanoparticles

ICYMI: Transparency of medical artificial intelligence systems

Medical #AI errors “can directly impact people’s health and even determine life-altering outcomes.” In @natrevbioeng.nature.com, @chanwoo-kim.bsky.social @sohamgadgil.bsky.social & @suinlee.bsky.social discuss the importance of transparency in medical models. www.washington.edu/news/2025/09...

Transparency of medical artificial intelligence systems

ICYMI: AI-driven protein design

AI-driven protein design

Genetically targeted chemical assembly uses cell-specific genetic information to guide the assembly of functional materials in situ. This article discusses how this concept can be applied for fundamental research and the treatment of diseases:

New publication from the lab -Bioremediation of heavy metal(loid)s in agricultural soils and crops in @natrevbioeng.nature.com led by Ravi Naidu, Bhabananda Biswas, Md Nuruzzaman @fao.org @unep.org www.nature.com/articles/s44...

ICYMI: A clinical roadmap for base and prime editing

ICYMI: Floss-based vaccination

Floss-based vaccination

A clinical roadmap for base and prime editing

Infections associated with medical device use can have serious consequences for patients, which might be addressed using medical devices with antimicrobial effects. This article discusses preclinical performance testing of medical devices with antimicrobial effects:

ICYMI: Evaluation and prediction of guide RNA activities in genome-editing tools

Evaluation and prediction of guide RNA activities in genome-editing tools

Tumour heterogeneity comes at different length scales.This article classifies regulators of cancer into tumour-cell-intrinsic, tissue-microenvironment and organism-level sources, describing engineering strategies to measure and analyse these factors:

Ischaemic stroke remains a leading cause of disability. This article discusses the design of biomaterials that can engage and modulate pro-repair mechanisms in the brain to improve repair after ischaemic stroke:

Kidney transplantation is the only definitive treatment for end-stage kidney disease. This article explores challenges in renal replacement and highlights the clinical potential of bioengineering approaches to restore kidney function:

The clinical application of CAR T cell therapy remains limited owing to off-target toxicity. This article discusses the remote and spatiotemporal control of CAR T cells by combining stimuli-responsive nanotechnologies with immunoengineering:

ICYMI: Multi-dimensional metagenomics

Multi-dimensional metagenomics

ICYMI: Precision dosimetry in pulmonary drug delivery